Marja Van Kampen

This inventor holds 29 USPTO granted patents and 4 published patent applications, plus 9 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim International Gmbh, Bayer Intellectual Property Gmbh, Bayer Healthcare Aktiengesellschaft. Active years: 2006-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marja Van Kampen. Retrieved from https://idiyas.com/inventor/marja-van-kampen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 4)

% Patents Active = 48.3

CIPO Patents = 9

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 7.5

ph-index = 9

Forward Citations = 267(Granted Patents)

Location History:

Düsseldorf, DE (2006 - 2014)
Dusseldorf, DE (2012 - 2017)
Neu-Isenburg, DE (2007 - 2019)
Neu-Lsenburg, DE (2019)

Company Filing History:

12 out of 1,564

Boehringer Ingelheim International Gmbh

patents

8 out of 721

Bayer Intellectual Property Gmbh

patents

4 out of 77

Bayer Healthcare Aktiengesellschaft

patents

4. 4 out of 192

Bayer Schering Pharma Ag

patents

5. 1 out of 1

Bayer Schering Pharma Aktiengesellshaft

patent

Years Active: 2006-2019

Loading Chart...

Areas of Expertise:

Azabicyclic Compounds

PDE Inhibitors

Carboxamides

Cognitive Enhancement

Pyrazolopyrimidines

Nicotinic Acetylcholine Receptor

Medicinal Chemistry

Acetic Acid Amides

Pharmaceutical Patents

Chemical Synthesis

Memory Improvement

Cognitive Processes

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10414762 - Amides of acetic and propionic acids (2019-09-17),

2. 10214524 - 2-heteroaryl carboxamides (2019-02-26),

3. 10196388 - Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists (2019-02-05),

4. 9914729 - Amides of acetic and propionic acids (2018-03-13),

5. 9714242 - Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists (2017-07-25),

6. 9067945 - Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes (2015-06-30),

7. 9067931 - 2-heteroaryl carboxamides (2015-06-30),

8. 8884017 - 2-heteroarylcarboxylic acid amides (2014-11-11),

9. 8822479 - 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines (2014-09-02),

10. 8809348 - 6-arylmethyl substituted pyrazolo[3,4-d]pyrimidines (2014-08-19),

11. 8772511 - Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists (2014-07-08),

12. 8741907 - Alkyl-substituted pyrazolopyrimidines (2014-06-03),

13. 8642605 - 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines (2014-02-04),

14. 8518967 - Amides of acetic and propionic acids (2013-08-27),

15. 8455502 - Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes (2013-06-04),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I would like to kindly inform you that I am currently not able to provide extended articles with the requested structure. If you need brief information, I would be happy to assist.

Profile summary based on public USPTO records.